Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43

Xconomy

JUNE 26, 2018

But that is starting to change, as Asian cities—particularly in China—are snapping up more tech venture capital funding and exits, according to a new report from CB Insights. But Beijing and Shanghai startups appear to be working to keep pace, reeling in $72.

Startup 84

Startup Report Venture Capital Research 84

Xconomy

JANUARY 7, 2020

Eventually Celgene kicked in $35 million more for a research collaboration, an equity stake, and an exclusive option to acquire the startup, PharmAkea Therapeutics.

Seed Funding 63

Seed Funding Equity Research Acquisition 63

Xconomy

SEPTEMBER 19, 2016

For the life sciences industry, one of the largest landlords, and closest observers, is Alexandria Real Estate Equities. from San Francisco, San Diego, and Seattle on the west coast to Boston, New York, and Research Triangle Park out east. Lately, Alexandria is aggressively expanding its reach.

Venture Capital 40

Venture Capital Startup San Diego Class 40

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

MAY 30, 2016

What, I think, is the first technology-based, early-stage venture capital fund anywhere, American Research and Development , was founded between Georges Doriot at Harvard Business School and Karl Compton, who was president of MIT at the time. Twenty years ago, everybody in Boston knew he was.

Startup 67

Startup Compton Research Technology 67

Xconomy

NOVEMBER 30, 2018

A Chinese researcher, He Jiankui, claimed he helped bring to life two genetically engineered babies, twin girls with a gene disabled to make them immune to HIV infection. This was one of those weeks when the world seemed to slip into a new era with no going back.

Research 70

Research Help Technology Venture Capital 70

socalTECH

MARCH 31, 2014

He ran DARPA research out of UC Irvine for almost a decade, until stepping out and focusing purely on entrepreneurial efforts. To give you an overview, there are something like 6,000 equities in the U.S. It wouldn''t be covered in the Los Angeles Times, and not by the San Diego papers. We''re using state of the art tools.

Orange County 245

Orange County Startup News IBM 245

Xconomy

SEPTEMBER 21, 2016

We’d like to thank the launch sponsors/underwriters who have joined us to support this new channel: Alexandria Real Estate Equities, Michigan State University, the North Carolina Biotechnology Center, and Spensa Technologies. and Cybersecurity. Xconomy editors around our network will be contributing to the new channel.

Newsletter 40

Newsletter Research Technology Equity 40

Xconomy

OCTOBER 20, 2016

As Xconomy reported last year, South San Francisco, CA-based BlackThorn was spun out of Scripps Research Institute , which on its website lists the company as one of its 2013 spinouts. It’s emerging from clinical research.”. Today they’re finally shedding a little light on what they’ve been up to.

Research 40

Research Study Press Equity 40

Xconomy

FEBRUARY 28, 2018

A core element in this universe is the invention of new kinds of credentials that attest to an independent learner’s mastery of skills that are in demand by employers, such as coding, critical thinking, and even physical tasks such as research laboratory techniques. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Education 45

Education Report Demand Research 45

Xconomy

NOVEMBER 21, 2016

But this is no time to trash talk the IPO market, according to Kathleen Smith of Renaissance Capital , a Greenwich, CT, firm that manages IPO-focused Exchange Traded Funds. The institutional research firm is predicting a surge of IPOs in the weeks and months to come. Smith anticipates a flurry of IPOs between Thanksgiving.

Research 40

Research Activity Capital Funding 40

Xconomy

JUNE 14, 2019

Is one of the bigger biopharma acquisitions of the year in trouble? This past week, antitrust regulators once again delayed Roche’s planned $4.8 billion buyout of gene therapy developer Spark Therapeutics (NASDAQ: ONCE ).

News 97

News Competition Acquisition Report 97

Xconomy

MAY 17, 2019

Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. But such tools only work when companies play fair.

Pricing 79

Pricing Competition Tool Marketing 79